Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Pulmokine in April, 2016 for $337,324.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL132709-01 | Phase I | 337,324 | April 7, 2016 | |||||||
A SBIR Phase II contract was awarded to Pulmokine in August, 2015 for $2,999,131.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HL102946-04 | Phase II | 2,999,131 | August 1, 2015 | |||||||
A SBIR Phase I contract was awarded to Pulmokine in April, 2017 for $515,573.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL135910-01A1 | Phase I | 515,573 | April 1, 2017 | |||||||
A SBIR Phase II contract was awarded to Pulmokine for $2,267,504.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HL102946-02 | Phase II | 2,267,504 | ||||||||
A SBIR Phase I contract was awarded to Pulmokine for $311,629.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL097529-01A1 | Phase I | 311,629 | ||||||||
A SBIR Phase I contract was awarded to Pulmokine for $351,008.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL102946-01 | Phase I | 351,008 | ||||||||
A SBIR Phase I contract was awarded to Pulmokine for $224,960.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43AI130015 | Phase I | 224,960 |